betamethasone dipropionate · Fougera · NDA 019136, 019137, 019140, 019141
Betamethasone Dipropionate
Earliest generic entry, as listed · earliest of 2 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- 25 Oct 2026Generic approved · 019137-00126 Jan 2026
Products covered · 4
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 019136 · 001 · discontinued | cream, topical | EQ 0.05% BASE | open |
| 019137 · 001 · RLD | cream, topical | EQ 0.05% BASE | open |
| 019140 · 001 · discontinued | ointment, topical | EQ 0.05% BASE | open |
| 019141 · 001 · RLD | ointment, topical | EQ 0.05% BASE | open |